Peripartum Cardiomyopathy Clinical Trial
Official title:
Creation of a Multicenter National Registry for Peripartum Cardiomyopathy: a Wide, Multidisciplinary and Translational Perspective to Achieve Personalized Medicine for a Rare Disease in Women
Peripartum cardiomyopathy (PPCM) is a rare, severe and potentially life-threatening disorder of largely unknown etiology and pathophysiology, with unexplained geographical differences and heterogeneous presentation. Investigators hypothesize that a network-based multidisciplinary strategy integrating clinical and molecular phenotyping of PPCM patients might anticipate diagnosis, optimize treatments, and identify novel mechanisms to achieve the unmet goal of personalized medicine.
Specific aims of this study are: a) to create a multicenter pilot registry of PPCM in different areas in Italy to assess incidence and prevalence of this rare disease, associated comorbidities and risk factors. b) to deeply characterize identified PPCM patients through clinical, imaging, genetic, biochemical, and molecular phenotyping. c) to gain novel mechanistic information on PPCM by performing deep clinical and molecular phenotyping in available biobanks samples of patients with PPCM and healthy controls. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04144660 -
"Treatment Use of ECMO In Pregnancy or Peripartum Patient."
|
||
Withdrawn |
NCT04143997 -
Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery
|
||
Completed |
NCT00998556 -
Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
|
Phase 2 | |
Completed |
NCT03081949 -
Peripartum Cardiomyopathy in Nigeria Registry
|
Phase 4 | |
Recruiting |
NCT03364140 -
A Registry of Peripartum Cardiomyopathy in Turkey
|
N/A | |
Completed |
NCT04049136 -
NT-proBNP Levels and Obesity in Pregnancy
|
||
Recruiting |
NCT04234659 -
PPCM Observational Study (Peripartum Cardiomyopathy)
|
||
Withdrawn |
NCT02590601 -
Bromocriptine in the Treatment of Peripartum Cardiomyopathy
|
Phase 3 | |
Completed |
NCT03907267 -
Taurine in Peripartum Cardiomyopathy
|
Phase 2/Phase 3 | |
Recruiting |
NCT04927715 -
Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.
|